Sep 30, 2023
D(+)-trehalose dihydrate is a stable non-reducing disaccharide. It can form a protective film on the surface of cells under various environmental stresses such as extreme heat, cold, drought, effectiv...
Sep 25, 2023
In the previous issue, we shared the study on the use of D(+)-trehalose dihydrate in cryopreservation of human oligodendrocyte precursor cells (OPCs). The study concluded that the cryopreservation med...
Sep 11, 2023
In the first three issues, we shared the studies of D(+)-trehalose dihydrate in the cryoprotection of human oligodendrocyte precursor cells (OPCs), adipose-derived stem cells (ADSCs), mouse testicular...
Aug 17, 2023
Haikou City, Hainan Province On 30 July 2023, with the support of the People's Government of Hainan Province, the first China Capital of Medical Aesthetic Industry Summit Forum & Expo (CMAIE) ...
Jul 13, 2023
AVT has participated in CPhI China 2023 at Shanghai, China from 19 - 21 June. Our booth no. is E4D22.Thanks for meeting us and having fruitful discussions about AVT's injectable pharmaceutical exc...
May 15, 2023
Injectable formulations often need to add certain excipients as solubilizers, stabilizers, and shaping agents. Improper selection of excipients may pose a safety hazard for injectables, which are dire...
May 08, 2023
Previous studies have shown that pharmaceutical excipients are inert substances. Therefore, if patients experience adverse reactions during clinical treatment, it is usually attributed to the toxicity...
May 01, 2023
Abstract:1. Prescription sharing of CD22-ADC drug Ogayitozumab ozogamicin (Besponsa)2. Introduction of CD22 targets and marketed and under development drugsText: Tris is a common buffer system in bioch...
